10377
0
Posted on Dec 30, 2005, 8 p.m.
By Bill Freeman
GENERAL DESCRIPTION: MGN-3 is produced by integrating an extract from the outer shell of rice bran with extracts from three different types of mushroom
GENERAL DESCRIPTION:
MGN-3 is produced by integrating an extract from the outer shell of rice bran with extracts from three different types of mushroom&emdash;shiitake, kawaratake, and suehirotake. In Japan, extracts of these three mushrooms are leading prescription treatments for cancer.
ROLE IN ANTI-AGING:
MGN-3 strengthens the immune system by boosting the activity of natural killer cells, Tcells and B-cells. Cancer patients have used MGN-3 both as a treatment and as an adjunct to lessen the toxicity of conventional therapies and improve their effectiveness. MGN-3 also has been used successfully, though to a lesser extent, with AIDS patients and patients with hepatitis B and C.
DEFICIENCY SYMPTOMS:
Not applicableTHERAPEUTIC DAILY AMOUNT:
Depends largely upon preparation used. One clinical study gave participants 3g per day for 6-months with no reports of adverse effects.
MAXIMUM SAFE LEVEL: Not established
SIDE EFFECTS/CONTRAINDICATIONS:
None known
